Skip to main content
OpenTrials

Clinical trial condition

ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC

Explore clinical trials studying ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC trial results

Completed

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

NCT01970865

Conditions
ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Highlands Oncology Group/Research Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • UC Irvine Medical Center Orange, California, United States
View all 77 locations
View Trial Details

Related conditions